|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers 显示文摘 | Mallikaarjun S Salazar DE Bramer SL | 2004 | J Clin Pharmacol2004，44，2： | 1 |
| 2 | Effect of grapefruit juice on the pharmacokinetics of tolvaptan, a non-peptide arginine vasopres- sin antagonist, in healthy subjects 显示文摘 | Shoaf SE Mallikaarjun S Bricmont P | 2012 | Eur J Clin Pharmacol2012，68，2： | 1 |
| 3 | Phar-macokinetics,tolerability,and safety of aripiprazole following multiple oral dosing in normal healthy volunteers显示文摘 | MALLIKAARJUN S SALAZAR D E BRAMER S L | 2004 | J Clin Pharmacol2004，44，2： | 1 |
| 4 | Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers显示文摘 | Mallikaarjun S Salazar DE Bramer SL | 2004 | J Clin Pharmacol2004，44，2： | 1 |
| 5 | Cilostazol Pharmacokinetics after Single and Multiple Oral Doses in Healthy Males and Patients with Intermittent Claudication Resulting from Peripheral Arterial Disease显示文摘 | Bramer SL Forbes WP Mallikaarjun S | 1999 | Clinical Pharmacokinet1999，37，2： | 1 |
| 6 | Pharmacokinetic and pharmacodynamic in- teraction between tolvaptan and warfarin in healthy subjects显示文摘 | Shoal S Mallikaarjun S | 2012 | Clin Pharmaeol Drug2012，1，2： | 1 |
| 7 | Pharmacokinetics,tolerability,and safety of aripiprazole following multiple oral dosing in normal healthy volunteers显示文摘 | S Mallikaarjun D E Salazar S L Bramer | | 0，，： | 1 |
| 8 | Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers显示文摘 | MALLIKAARJUN S SALAZAR DE BRAMER S | 2004 | J Clin Pharmacol2004，44，2： | 1 |
| 9 | Pharmacokinetics, tolerability,and safety of aripiprazole following multiple oral dosing in normal healthy volunteers显示文摘 | Mallikaarjun S Salazar DE Bramer SL | 2004 | J Clin Pharmacol2004，44，2： | 1 |
| 10 | Pharmacokinetics,tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers显示文摘 | Mallikaarjun S Salazar DE Bramer SL | 2004 | J Clin Pharmacol2004，44，2： | 1 |
| 11 | Population pharmacokinetics of tolvaptan in healthy subjects and patients with hyponatremia secondary to congestive heart failure or hepatic cirrhosis显示文摘 | Scott A. Van Wart Susan E. Shoaf Suresh Mallikaarjun Donald E. Mager | 2013 | Biopharm. Drug Dispos2013，，6： | 1 |
| 12 | Pharmacokinetics, tolerability,and safety of aripiprazole following multiple oral dosing in normal healthy volunteers显示文摘 | Mallikaarjun S Salazar D E Bramer S L | 2004 | J clin Pharmacol2004，44，2： | 1 |
| 13 | Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers显示文摘 | Mallikaarjun S Salazar DE Bramer SL | 2004 | J Clin Pharmacol2004，44，： | 1 |
| 14 | Effect of grapefruit juice on the pharmacokinetics of tolvaptan, a non-peptide arginine vasopressin antagonist,in healthy subjects显示文摘 | Shoaf SE Mallikaarjun S Bricmont P | 2012 | Eur J Clin Pharmacol2012，68，2： | 1 |
| 15 | The effects of hepatic impairment on the pharmacokinetics of aripiprazole 显示文摘 | Mallikaarjun S Tammara BK Salazar DE | 2002 | Clin Pharmacol Ther2002，71，： | 1 |
| 16 | The effects of age and gender on the pharmacokinetics of aripiprazole 显示文摘 | Mallikaarjun S Ali MW Salazar DE | 2002 | Clin Pharmacol Ther2002，71，： | 1 |
| 17 | Pharrnaeokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in Normal Healthy Volunteers显示文摘 | Mallikaarjun S Salazar D E Bramer S L | | J Clin Pharmaeol0，44，： | 1 |
| 18 | Pharmacoki netics, tolerability, and safety of aripiprazole fol lowing multiple oral dosing in normal healthy volun teers显示文摘 | Mallikaarjun S Salazar DE Bramer SL | 2004 | J Clin Pharmacol2004，44，2： | 1 |
| 19 | Effect of grapefruit juice on the pharmacokinetics of tolvaptan, a non-peptide arginine vasopressin antagonist,in healthy subjects显示文摘 | Shoaf SE Mallikaarjun S Briemont P | 2012 | Eur J Clin Pharmacol2012，68，2： | 1 |
| 20 | Pharmacokinetics,tolerability,and safety of aripiprazole following multiple oral dosing in normal healthy volunteers显示文摘 | MALLIKAARJUN S SALAZAR D E BRAMER S L | 2004 | J Clin Pharmacol2004，44，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员